Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (2021) Coates LC, Gossec L, Theander E, Bergmans P, Neuhold M, Karyekar CS, Shawi M, et al. Journal article Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA (2021) Martinsson K, Dürholz K, Schett G, Zaiss M, Kastbom A Journal article Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease (2021) Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, et al. Journal article Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis (2021) O'Neil LJ, Hu P, Liu Q, Islam MM, Spicer V, Rech J, Hueber A, et al. Journal article Reframing immune-mediated inflammatory diseases (2021) Boutrid N, Rahmoune H, Schett G, McInnes I, Neurath M Journal article IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation (2021) Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, et al. Journal article More on CD19-CAR T Cells in Systemic Lupus Erythematosus (2021) Mougiakakos D, Krönke G, Schett G Journal article, Letter Virtual teaching for medical students during SARS-CoV-2 pandemic (2021) Pfeil A, Franz M, Hoffmann T, Klemm P, Oelzner P, Muller-Ladner U, Lange U, et al. Journal article, Letter The role of IL-23 in joint disease (2021) Schett G Journal article, Editorial Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis (2021) Pournara E, Kormaksson M, Nash P, Ritchlin CT, Kirkham BW, Ligozio G, Pricop L, et al. Journal article